Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2012, Article ID 715049, 12 pages
http://dx.doi.org/10.1155/2012/715049
Clinical Study

Impairment and Differential Expression of PR3 and MPO on Peripheral Myelomonocytic Cells with Endothelial Properties in Granulomatosis with Polyangiitis

1Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany
2Core Facility “Molecular & Optical Live Cell Imaging (MOLCI)”, University Medical Center Göttingen, 37075 Göttingen, Germany

Received 24 March 2012; Revised 30 April 2012; Accepted 7 May 2012

Academic Editor: Alejandro Martín-Malo

Copyright © 2012 Susann Patschan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Godman and J. Churg, “Wegener's granulomatosis: pathology and review of the literature,” A. M. A. Archives of Pathology, vol. 58, no. 6, pp. 533–553, 1954. View at Google Scholar · View at Scopus
  2. B. E. P. B. Ballieux, K. T. Zondervan, P. Kievit et al., “Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?” Clinical and Experimental Immunology, vol. 97, no. 1, pp. 52–60, 1994. View at Google Scholar · View at Scopus
  3. A. Woywodt, C. Goldberg, T. Kirsch et al., “Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 164–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ohlsson, T. Hellmark, K. Pieters, G. Sturfelt, J. Wieslander, and M. Segelmark, “Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis,” Clinical and Experimental Immunology, vol. 141, no. 1, pp. 174–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Google Scholar · View at Scopus
  7. A. Y. Khakoo and T. Finkel, “Endothelial progenitor cells,” Annual Review of Medicine, vol. 56, pp. 79–101, 2005. View at Google Scholar
  8. D. Patschan, M. Plotkin, and M. S. Goligorsky, “Therapeutic use of stem and endothelial progenitor cells in acute renal injury: Ça ira,” Current Opinion in Pharmacology, vol. 6, no. 2, pp. 176–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Urbich and S. Dimmeler, “Endothelial progenitor cells: characterization and role in vascular biology,” Circulation Research, vol. 95, no. 4, pp. 343–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Urbich and S. Dimmeler, “Endothelial progenitor cells: functional characterization,” Trends in Cardiovascular Medicine, vol. 14, no. 8, pp. 318–322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Case, L. E. Mead, W. K. Bessler et al., “Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors,” Experimental Hematology, vol. 35, no. 7, pp. 1109–1118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. C. Yoder, L. E. Mead, D. Prater et al., “Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals,” Blood, vol. 109, no. 5, pp. 1801–1809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. De Groot, C. Goldberg, F. H. Bahlmann et al., “Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis,” Arthritis and Rheumatism, vol. 56, no. 11, pp. 3847–3853, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Závada, L. Kideryová, R. Pytlík, Z. Vaňková, and V. Tesař, “Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis,” Kidney and Blood Pressure Research, vol. 31, no. 4, pp. 247–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Finkielman, P. A. Merkel, D. Schroeder et al., “Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis,” Annals of Internal Medicine, vol. 147, no. 9, pp. 611–619, 2007. View at Google Scholar · View at Scopus
  16. N. Hu, J. Westra, and C. G. M. Kallenberg, “Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis,” Autoimmunity Reviews, vol. 8, no. 6, pp. 510–514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Lamprecht, “New pathogenetic aspects in primary systemic vasculitides,” Internist, vol. 50, no. 3, pp. 291–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Wikman, A. Fagergren, S. G. O. Johansson, J. Lundahl, and S. H. Jacobson, “Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis,” Nephrology Dialysis Transplantation, vol. 18, no. 9, pp. 1792–1799, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Y. Leavitt, A. S. Fauci, D. A. Bloch et al., “The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis,” Arthritis and Rheumatism, vol. 33, no. 8, pp. 1101–1107, 1990. View at Google Scholar · View at Scopus
  20. R. A. Luqmani, P. A. Bacon, R. J. Moots et al., “Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis,” Quarterly Journal of Medicine, vol. 87, no. 11, pp. 671–678, 1994. View at Google Scholar · View at Scopus
  21. L. Somogyi, N. Cikes, and M. Marusic, “Evaluation of criteria contributions for the classification of systemic lupus erythematosus,” Scandinavian Journal of Rheumatology, vol. 22, no. 2, pp. 58–62, 1993. View at Google Scholar · View at Scopus
  22. C. Bombardier, D. D. Gladman, M. B. Urowitz, D. Caron, and Chi Hsing Chang, “Derivation of the SLEDAI: a disease activity index for lupus patients,” Arthritis and Rheumatism, vol. 35, no. 6, pp. 630–640, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Google Scholar · View at Scopus
  24. D. Patschan, K. Krupincza, S. Patschan, Z. Zhang, C. Hamby, and M. S. Goligorsky, “Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning,” American Journal of Physiology, vol. 291, no. 1, pp. F176–F185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Romagnani, F. Annunziato, F. Liotta et al., “CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors,” Circulation Research, vol. 97, no. 4, pp. 314–322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Patschan, S. Patschan, J. T. Wessels et al., “Epac-1 activator 8-O-cAMP augments renoprotective effects of allogeneic murine EPCs in acute ischemic kidney injury,” American Journal of Physiology, vol. 298, no. 1, pp. F78–F85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Patschan, S. Patschan, E. Henze, J. T. Wessels, M. Koziolek, and G. A. Müller, “LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence,” Journal of Clinical Apheresis, vol. 24, no. 5, pp. 180–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. De Groot, F. H. Bahlmann, J. Sowa et al., “Uremia causes endothelial progenitor cell deficiency,” Kidney International, vol. 66, no. 2, pp. 641–646, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Fukuhara, K. Sako, K. Noda, J. Zhang, M. Minami, and N. Mochizuki, “Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis,” Histology and Histopathology, vol. 25, no. 3, pp. 387–396, 2010. View at Google Scholar · View at Scopus
  30. F. Chen, Z. Tan, C. Dong et al., “Combination of VEGF165/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization,” European Journal of Pharmacology, vol. 568, no. 1–3, pp. 222–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Brachemi, A. Mambole, F. Fakhouri et al., “Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti-proteinase 3 antibodies,” Journal of the American Society of Nephrology, vol. 18, no. 8, pp. 2330–2339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Kurth, K. Franke, T. Pompe, M. Bornhäuser, and C. Werner, “Hematopoietic stem and progenitor cells in adhesive microcavities,” Integrative Biology, vol. 1, no. 5-6, pp. 427–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Schlechta, D. Wiedemann, C. Kittinger et al., “Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration,” Circulation Journal, vol. 74, no. 1, pp. 188–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Tárnok, H. Ulrich, and J. Bocsi, “Phenotypes of stem cells from diverse origin,” Cytometry Part A, vol. 77, no. 1, pp. 6–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Kümpers, S. David, M. Haubitz et al., “The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1638–1643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. N. A. Abdel-Malak, M. Mofarrahi, D. Mayaki, L. M. Khachigian, and S. N. A. Hussain, “Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 2, pp. 209–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Acquavella, M. F. Quiroga, O. Wittig, and J. E. Cardier, “Effect of simvastatin on endothelial cell apoptosis mediated by Fas and TNF-α,” Cytokine, vol. 49, no. 1, pp. 45–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Wang, H. M. Liu, M. G. Irwin et al., “Role of protein kinase C β2 activation in TNF-α-induced human vascular endothelial cell apoptosis,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 3, pp. 221–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Wu, R. Guo, P. Chen, Q. Wang, and P. N. Cunningham, “TNF induces caspase-dependent inflammation in renal endothelial cells through a rho- and myosin light chain kinase-dependent mechanism,” American Journal of Physiology, vol. 297, no. 2, pp. F316–F326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Xia, T. Luo, H. M. Liu et al., “L-arginine enhances nitrative stress and exacerbates tumor necrosis factor-α toxicity to human endothelial cells in culture: prevention by propofol,” Journal of Cardiovascular Pharmacology, vol. 55, no. 4, pp. 358–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Lamprecht, J. Holle, and W. L. Gross, “Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitides,” Current Drug Discovery Technologies, vol. 6, no. 4, pp. 241–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Mauro, G. M. Rigolin, C. Fraulini et al., “Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation,” European Journal of Haematology, vol. 78, no. 5, pp. 374–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Grisar, D. Aletaha, C. W. Steiner et al., “Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy,” Annals of the Rheumatic Diseases, vol. 66, no. 10, pp. 1284–1288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. U. Holle, Q. J. Wu, F. Moosig, W. L. Gross, and E. Csernok, “Membrane proteinase 3 (mPR3) expression on neutrophils is not increased in localised Wegener's granulomatosis (WG) and Churg-Strauss syndrome (CSS),” Clinical and Experimental Rheumatology, vol. 28, no. 1, pp. S46–S50, 2010. View at Google Scholar · View at Scopus
  45. D. Patschan, S. Patschan, and G. A. Muller, “Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence,” International Journal of Nephrology, vol. 2011, Article ID 828369, 7 pages, 2011. View at Publisher · View at Google Scholar
  46. S. Y. Schubert, A. Benarroch, J. Monter-Solans, and E. R. Edelman, “Monocyte activation state regulates monocyte-induced endothelial proliferation through Met signaling,” Blood, vol. 115, no. 16, pp. 3407–3412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Kantari, M. Pederzoli-Ribeil, O. Amir-Moazami et al., “Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis,” Blood, vol. 110, no. 12, pp. 4086–4095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. E. C. Hagen, B. E. P. B. Ballieux, L. A. Van Es, M. R. Daha, and F. J. Van der Woude, “Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences,” Blood, vol. 81, no. 8, pp. 1996–2002, 1993. View at Google Scholar · View at Scopus
  49. F. J. Van Der Woude, M. R. Daha, and L. A. Van Es, “The current status of neutrophil cytoplasmic antibodies,” Clinical and Experimental Immunology, vol. 78, no. 2, pp. 143–148, 1989. View at Google Scholar · View at Scopus
  50. F. J. Van der Woude, E. Schrama, L. A. Van Es, F. J. H. Claas, and M. R. Daha, “The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantation,” Transplant Immunology, vol. 2, no. 4, pp. 271–277, 1994. View at Google Scholar · View at Scopus
  51. W. F. Pendergraft, E. H. Rudolph, R. J. Falk et al., “Proteinase 3 sidesteps caspases and cleaves p21Waf1/Cip1/Sdi1 to induce endothelial cell apoptosis,” Kidney International, vol. 65, no. 1, pp. 75–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. J. J. Yang, R. Kettritz, R. J. Falk, J. C. Jennette, and M. L. Gaido, “Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase,” American Journal of Pathology, vol. 149, no. 5, pp. 1617–1626, 1996. View at Google Scholar · View at Scopus